Beijing Beilu Pharmaceutical Co., Ltd (SHE:300016)

HashiCorp Revenue

Beijing Beilu Pharmaceutical had revenue of 282.68M CNY in the quarter ending March 31, 2025, with 36.23% growth. This brings the company's revenue in the last twelve months to 1.06B, up 16.32% year-over-year. In the year 2024, Beijing Beilu Pharmaceutical had annual revenue of 983.55M with 10.42% growth.

• Revenue (ttm): 1.06B
• Revenue Growth: +16.32%
• P/S Ratio: 4.83
• Revenue / Employee: 902.58K
• Employees: 1,173
• Market Cap: 5.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	983.55M	92.84M	10.42%
Dec 31, 2023	890.72M	124.84M	16.30%
Jan 1, 2023	765.88M	-94.02M	-10.93%
Jan 1, 2022	859.91M	32.57M	3.94%
Dec 31, 2020	827.34M	8.22M	1.00%